Biotech Values

[caravon]

Paying $3-5B for ABBV, NVS or any Big Pharma for ENTA means nothing.

MRK just paid for $3.8B for a biotech with nothing to file in the next 3-4 years. And finally, too many very promising drugs fail in their registration trials.